1
Conclusions: Bone loss associated with various cancer therapies significantly affects bone health.
2
MicroRNAs have been reported to play a role in various cancer types.
3
It showed wide expression in various cancer tissues and cancer cell lines.
4
JARID1B is an epigenetic factor with reported oncogenic potential in various cancer types.
5
These SNPs have been increasingly studied in the epidemiology of various cancer types.
6
Increased survivin expression has been found in various cancer types, including gastric cancer.
7
They can induce differentiation and apoptosis in various cancer cells.
8
Our findings will also inform future ACT trials with various cancer populations and functional outcomes.
9
Deregulated miRNAs can have profound impacts on various cancer hallmarks by repressing tumor suppressor genes.
10
SERCA3 expression is restored during the pharmacologically induced differentiation of various cancer and leukemia cell types.
11
Methods: The antibody panel used for the RPPA included 130 key proteins involved in various cancer-related pathways.
12
Emerging as a new modality of modern cancer treatments, immunotherapy has shown promises for various cancer types.
13
Quantitative changes in human mitochondrial DNA (mtDNA) copy number have been implicated in various cancer types.
14
The effect of the vectorized paclitaxel on various cancer cells was not significantly different from that of free paclitaxel.
15
Here, we find that chemotherapy-induced DNA damage leads to the rapid degradation of BRD7 in various cancer cell lines.
16
On the other hand, activation of the transcription factor NF-kappaB can prevent apoptosis in various cancer cells and neurons.
